BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Su C, Jiang Z, Yang Y, Zhang Y, Yang M, Zhang X, Du Y, Zhang J, Wang L, Jiang J, Hong B. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. NPJ Biofilms Microbiomes 2021;7:36. [PMID: 33863898 DOI: 10.1038/s41522-021-00205-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hong B, Jiang J. Treating chronic diseases by regulating the gut microbiota. Engineering 2021. [DOI: 10.1016/j.eng.2021.08.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xing L, Zhou X, Li AH, Li HJ, He CX, Qin W, Zhao D, Li PQ, Zhu L, Cao HL. Atheroprotective Effects and Molecular Mechanism of Berberine. Front Mol Biosci 2021;8:762673. [PMID: 34869592 DOI: 10.3389/fmolb.2021.762673] [Reference Citation Analysis]
3 Chen Y, Wang M. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes. Drug Des Devel Ther 2021;15:4849-63. [PMID: 34876807 DOI: 10.2147/DDDT.S334325] [Reference Citation Analysis]
4 Shan S, Yin R, Shi J, Zhang L, Liu F, Qiao Q, Li Z. Bowman-Birk Major Type Trypsin Inhibitor Derived from Foxtail Millet Bran Attenuate Atherosclerosis via Remodeling Gut Microbiota in ApoE-/- Mice. J Agric Food Chem 2022;70:507-19. [PMID: 34989223 DOI: 10.1021/acs.jafc.1c05747] [Reference Citation Analysis]
5 Panyod S, Wu WK, Chen PC, Chong KV, Yang YT, Chuang HL, Chen CC, Chen RA, Liu PY, Chung CH, Huang HS, Lin AY, Shen TD, Yang KC, Huang TF, Hsu CC, Ho CT, Kao HL, Orekhov AN, Wu MS, Sheen LY. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation. NPJ Biofilms Microbiomes 2022;8:4. [PMID: 35087050 DOI: 10.1038/s41522-022-00266-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
6 Cheng TY, Li JX, Chen JY, Chen PY, Ma LR, Zhang GL, Yan PY. Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease. Chin Med 2021;16:108. [PMID: 34686199 DOI: 10.1186/s13020-021-00516-0] [Reference Citation Analysis]
7 Dong F, Jiang S, Tang C, Wang X, Ren X, Wei Q, Tian J, Hu W, Guo J, Fu X, Liu L, Patzak A, Persson PB, Gao F, Lai EY, Zhao L. Trimethylamine N-oxide promotes hyperoxaluria-induced calcium oxalate deposition and kidney injury by activating autophagy. Free Radic Biol Med 2021:S0891-5849(21)00797-8. [PMID: 34767921 DOI: 10.1016/j.freeradbiomed.2021.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhou P, Kang JL, Cheng QQ, Chen MT, Xie Y, Zhou H. Therapeutic potential of traditional Chinese medicine against atherosclerosis: Targeting trimethylamine N-oxide. Phytomedicine 2022;104:154305. [PMID: 35792446 DOI: 10.1016/j.phymed.2022.154305] [Reference Citation Analysis]
9 Yang S, Li D, Yu Z, Li Y, Wu M. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Front Pharmacol 2021;12:709629. [PMID: 34305616 DOI: 10.3389/fphar.2021.709629] [Reference Citation Analysis]
10 Cretoiu D, Ionescu RF, Enache RM, Cretoiu SM, Voinea SC. Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications-Is There a Missing Link? Microorganisms 2021;9:1913. [PMID: 34576810 DOI: 10.3390/microorganisms9091913] [Reference Citation Analysis]
11 Li X, Hong J, Wang Y, Pei M, Wang L, Gong Z. Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD. Front Mol Biosci 2021;8:733507. [PMID: 34660695 DOI: 10.3389/fmolb.2021.733507] [Reference Citation Analysis]
12 Zhang X, Gérard P. Diet-gut microbiota interactions on cardiovascular disease. Comput Struct Biotechnol J 2022;20:1528-40. [PMID: 35422966 DOI: 10.1016/j.csbj.2022.03.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li W, Bai X, Hao J, Xu X, Lin F, Jiang Q, Ding C, Dai G, Peng F, Zhang M, Feng Y, Wang J, Chen X, Xue T, Guo X, Fu Z, Chen WH, Zhang L, Wang C, Jiao L. Thrombosis origin identification of cardioembolism and large artery atherosclerosis by distinct metabolites. J Neurointerv Surg 2022:neurintsurg-2022-019047. [PMID: 35654581 DOI: 10.1136/neurintsurg-2022-019047] [Reference Citation Analysis]
14 Park JW, Park IH, Kim JM, Noh JH, Kim KA, Park JY. Rapid detection of FMO3 single nucleotide polymorphisms using a pyrosequencing method. Mol Med Rep 2022;25:48. [PMID: 34913068 DOI: 10.3892/mmr.2021.12564] [Reference Citation Analysis]
15 Shen X, Li L, Sun Z, Zang G, Zhang L, Shao C, Wang Z. Gut Microbiota and Atherosclerosis-Focusing on the Plaque Stability. Front Cardiovasc Med 2021;8:668532. [PMID: 34414217 DOI: 10.3389/fcvm.2021.668532] [Reference Citation Analysis]
16 Cao RY, Zhang Y, Feng Z, Liu S, Liu Y, Zheng H, Yang J. The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis. Front Pharmacol 2021;12:764994. [PMID: 35002703 DOI: 10.3389/fphar.2021.764994] [Reference Citation Analysis]
17 Panyod S, Wu W, Chen C, Wu M, Ho C, Sheen L. Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases. Journal of Traditional and Complementary Medicine 2021. [DOI: 10.1016/j.jtcme.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chou S, Zhang S, Guo H, Chang Y, Zhao W, Mou X. Targeted Antimicrobial Agents as Potential Tools for Modulating the Gut Microbiome. Front Microbiol 2022;13:879207. [DOI: 10.3389/fmicb.2022.879207] [Reference Citation Analysis]
19 Hu H, Xu K, Wang K, Zhang F, Bai X. Dissecting the Effect of Berberine on the Intestinal Microbiome in the Weaned Piglets by Metagenomic Sequencing. Front Microbiol 2022;13:862882. [PMID: 35464928 DOI: 10.3389/fmicb.2022.862882] [Reference Citation Analysis]
20 Li Q, Wu T, Zhang M, Chen H, Liu R. Induction of the glycolysis product methylglyoxal on trimethylamine lyase synthesis in the intestinal microbiota from mice fed with choline and dietary fiber. Food Funct 2021;12:9880-93. [PMID: 34664588 DOI: 10.1039/d1fo01481a] [Reference Citation Analysis]
21 Luo T, Guo Z, Liu D, Guo Z, Wu Q, Li Q, Lin R, Chen P, Ou C, Chen M. Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3. Gut Microbes 2022;14:2077602. [PMID: 35613310 DOI: 10.1080/19490976.2022.2077602] [Reference Citation Analysis]
22 Wang Z, Wu F, Zhou Q, Qiu Y, Zhang J, Tu Q, Zhou Z, Shao Y, Xu S, Wang Y, Tao J. Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice. Front Microbiol 2022;13:814855. [PMID: 35350612 DOI: 10.3389/fmicb.2022.814855] [Reference Citation Analysis]
23 Li Y, Kang J, Lee Y, Chung JY, Cho JY. A validated simple LC-MS/MS method for quantifying trimethylamine N-oxide (TMAO) using a surrogate matrix and its clinical application. Transl Clin Pharmacol 2021;29:216-25. [PMID: 35024362 DOI: 10.12793/tcp.2021.29.e19] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]